Literature DB >> 2479648

Galanin receptor in the rat pancreatic beta cell line Rin m 5F. Molecular characterization by chemical cross-linking.

B Amiranoff1, A M Lorinet, M Laburthe.   

Abstract

125I-Galanin was cross-linked to receptor in Rin m 5F cell membranes using the bifunctional reagent disuccinimidyl tartarate. Regardless of the presence of reducing agents, sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of cross-linked galanin-receptor complexes revealed the presence of a radioactive band at Mr 57,000. Excess unlabeled galanin completely inhibited the labeling of the band while other regulatory peptides had no effect. Labeling of the Mr 57,000 complex was abolished by galanin concentration from 10(-9) to 10(-6) M (IC50 = 5 X 10(-9) M). Initial incubation with 125I-galanin in the presence of increasing concentrations of guanyl-5'-yl imidodiphosphate (GMP-P(NH)P) (10(-7) to 10(-4) M) also inhibited the labeling of the Mr 57,000 complex. Moreover, pretreatment of membranes with pertussis toxin before formation of the covalent galanin-receptor complex, dramatically reduced the labeling of the Mr 57,000 species. Covalent Mr 57,000 galanin-receptor complexes solubilized by Triton X-100 bound specifically to wheat germ agglutinin-concanavalin A-, and soybean-coupled Sepharose, supporting the glycoproteic nature of the galanin receptor. Assuming one molecule of 125I-galanin (Mr 3,000) was bound per molecule of protein, these results suggest that the pancreatic galanin receptor is a glycoprotein with a Mr of 54,000 bearing the recognition site for the ligand and which is coupled with a pertussis toxin-sensitive G protein in the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479648

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Galanin and the regulation of islet hormone secretion.

Authors:  B Ahrén; S Lindskog
Journal:  Int J Pancreatol       Date:  1992-06

2.  Molecular cloning of a functional human galanin receptor.

Authors:  E Habert-Ortoli; B Amiranoff; I Loquet; M Laburthe; J F Mayaux
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

3.  Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide.

Authors:  W E Schmidt; H Kratzin; K Eckart; D Drevs; G Mundkowski; A Clemens; S Katsoulis; H Schäfer; B Gallwitz; W Creutzfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  Possible evidence for endogenous production of a novel galanin-like peptide.

Authors:  Z L Wang; R N Kulkarni; R M Wang; D M Smith; M A Ghatei; P G Byfield; W M Bennet; S R Bloom
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 5.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

6.  Inhibition by galanin and by high K+ of human basophil histamine release triggered by calcium ionophores but not responses induced by anti-IgE, chemotactic peptide or phorbol ester.

Authors:  H Bergstrand; B Lundquist; B Ahrén
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Galanin inhibits a dihydropyridine-sensitive Ca2+ current in the RINm5f cell line.

Authors:  F R Homaidan; G W Sharp; L M Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Purification of a galanin receptor from pig brain.

Authors:  Y Chen; A Fournier; A Couvineau; M Laburthe; B Amiranoff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Mechanism of galanin's inhibitory action on pancreatic enzyme secretion: modulation of cholinergic transmission--studies in vivo and in vitro.

Authors:  K H Herzig; G Brunke; I Schön; M Schäffer; U R Fölsch
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

10.  Galanin-mediated control of pain: enhanced role after nerve injury.

Authors:  Z Wiesenfeld-Hallin; X J Xu; U Langel; K Bedecs; T Hökfelt; T Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.